Logo@2x
Phone

Talk To Our Team

2
Group 903

Pamela Demain

Senior Client Advisor

Biotechnology, Pharmaceuticals

Pamela Demain is a pharmaceutical and biotech leader, with over 40 years of global experience in pharmaceutical corporate development and licensing. Her accomplishments in combining negotiation of complex transactions at all stages of development and commercialization, leading relationship development, strategic planning expertise, and global marketing/brand leadership, make her an invaluable addition to the IGNITE Advisory Group and the IGNITE Network.

 

Pamela (Pam) has served on multiple boards, spoken at numerous international bio and pharma conferences, and has consulted for a wide variety of businesses, winning awards for her mentorship. She has led teams responsible for everything from corporate licensing to strategic relationship management.

 

pam

career accomplishments

Pam’s career accomplishments include:

Pamela Demain

Pam Demain has an M.B.A. in International Business, from the American University, Washington D.C., where she was the recipient of their University Award for Outstanding Achievement at Graduate Level, for her work as Grad Assistant in Marketing. She has a Bachelor of Arts in Anthropology, from the University of Massachusetts, where she graduated cum laude. Pam is a Certified Licensing Professional (CLP) and has completed Management and Finance Executive courses at Wharton School of Business, Harvard Business School Getting to Yes: Harvard Negotiating Project.

Spots01

Pam's

Areas of Excellence:

Group 901

Senior Executive Advisory Team

Meet the Senior Biotech Exec team

Group 625

Eamonn Hobbs

Partner & Senior Client Advisor

Biotechnology, Pharmaceuticals & Medical Device

Group 741

John Tushar

Senior Client Advisor

Medical Device

Group 740

Richard Otto

Senior Client Advisor

Biotechnology, Health IT & Medical Device

Spots01
Group 627

Russell Allen

Co-Founder and CEO

Group 626

Jamie Hennessy

Co-Founder and Treasurer

Group 628

Bill Knab

Senior Client Advisor

Medical Device

Untitled design (5)

William Dull

Chief Operating Officer

MedTech, Pharma, & Biotech

scott

Matthew White

CFA Partner